<SEC-DOCUMENT>0001816079-23-000004-index.html : 20231017
<SEC-HEADER>0001816079-23-000004.hdr.sgml : 20231017
<ACCEPTANCE-DATETIME>20231017122832
ACCESSION NUMBER:		0001816079-23-000004
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20231017
DATE AS OF CHANGE:		20231017
EFFECTIVENESS DATE:		20231017

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DMK PHARMACEUTICALS Corp
		CENTRAL INDEX KEY:			0000887247
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820429727
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36242
		FILM NUMBER:		231329068

	BUSINESS ADDRESS:	
		STREET 1:		11682 EL CAMINO REAL
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 997-2400

	MAIL ADDRESS:	
		STREET 1:		11682 EL CAMINO REAL
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adamis Pharmaceuticals Corp
		DATE OF NAME CHANGE:	20090406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLEGY PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950615

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hammann Jerald
		CENTRAL INDEX KEY:			0001816079

	FILING VALUES:
		FORM TYPE:		PX14A6G

	MAIL ADDRESS:	
		STREET 1:		1566 SUMTER AVE N
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55427-4048
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>PX14A6G887247820429727231017.htm
<DESCRIPTION>SHAREHOLDER JERALD HAMMANN DISCONTINUES DMK PHARMACEUTICALS CORP. PROXY CONTEST
<TEXT>
Document 1 - file: PX14A6G887247820429727231017.htm

</DOCUMENT>
</SEC-DOCUMENT>